Transgene(GB:0OCQ)
€0.72-0.01 (-1.23%)
GB:0OCQ
Transgene financials statements
€0.72
At close:-0.01 (-1.23%)
Transgene (0OCQ) Ratios
2 Followers
Transgene Ratios
GB:0OCQ's free cash flow for Q2 2026 was €-20.17M. For the 2026 fiscal year, GB:0OCQ's free cash flow was decreased by €-638.00K and operating cash flow was €-19.54M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 9.62 | 1.48 | 1.79 | 3.64 | 4.27 |
| Quick Ratio | 9.62 | 1.48 | 1.79 | 2.39 | 4.27 |
| Cash Ratio | 0.54 | 1.19 | 1.56 | 0.34 | 0.41 |
| Solvency Ratio | -2.12 | -1.21 | -0.70 | -1.09 | -0.51 |
| Operating Cash Flow Ratio | -3.00 | -1.68 | -3.45 | -1.59 | -2.19 |
| Short-Term Operating Cash Flow Coverage | -91.84 | -143.59 | -376.86 | 0.00 | -280.20 |
| Net Current Asset Value | € 100.59M | € -6.30M | € -11.62M | € 17.91M | € 27.62M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.01 | 0.25 | 0.03 | 0.04 | 0.04 |
| Debt-to-Equity Ratio | 0.02 | 0.68 | 0.09 | 0.06 | 0.06 |
| Debt-to-Capital Ratio | 0.02 | 0.41 | 0.08 | 0.06 | 0.05 |
| Long-Term Debt-to-Capital Ratio | 0.01 | 0.40 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.14 | 2.77 | 2.90 | 1.76 | 1.52 |
| Debt Service Coverage Ratio | -15.81 | -11.17 | -309.13 | -37.73 | -41.55 |
| Interest Coverage Ratio | -24.29 | -21.21 | 0.00 | -37.19 | -50.70 |
| Debt to Market Cap | 0.01 | 0.13 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.03 | 0.10 | 0.01 | 0.03 | 0.05 |
| Net Debt to EBITDA | 0.12 | 0.24 | 0.50 | 0.06 | 0.09 |
| Profitability Margins | |||||
| Gross Profit Margin | 100.00% | -439.56% | -274.53% | -929.05% | -229.06% |
| EBIT Margin | -8381.63% | -439.68% | -379.90% | -1023.67% | -190.85% |
| EBITDA Margin | -8116.33% | -419.52% | -360.00% | -970.15% | -235.66% |
| Operating Profit Margin | -8381.63% | -561.28% | -380.34% | -956.62% | -235.41% |
| Pretax Profit Margin | -9029.39% | -629.89% | -282.63% | -1049.39% | -195.50% |
| Net Profit Margin | -7657.96% | -534.72% | -282.63% | -1049.58% | -200.18% |
| Continuous Operations Profit Margin | -7657.96% | -534.72% | -282.63% | -1049.39% | -195.50% |
| Net Income Per EBT | 84.81% | 84.89% | 100.00% | 100.02% | 102.40% |
| EBT Per EBIT | 107.73% | 112.22% | 74.31% | 109.70% | 83.04% |
| Return on Assets (ROA) | -27.03% | -80.55% | -49.38% | -49.39% | -19.64% |
| Return on Equity (ROE) | -30.82% | -223.43% | -143.02% | -86.70% | -29.76% |
| Return on Capital Employed (ROCE) | -32.44% | -126.49% | -85.42% | -55.73% | -26.96% |
| Return on Invested Capital (ROIC) | -27.43% | -106.70% | -82.30% | -54.52% | -26.54% |
| Return on Tangible Assets | -27.04% | -80.67% | -49.47% | -49.44% | -19.66% |
| Earnings Yield | -27.08% | -42.82% | -16.06% | -19.89% | -8.64% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.13 | 5.36 | 8.71 | 1.07 | 0.00 |
| Payables Turnover | 0.00 | 3.61 | 6.51 | 4.62 | 4.27 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 2.01 | 0.00 |
| Fixed Asset Turnover | 0.04 | 0.44 | 0.64 | 0.28 | 0.88 |
| Asset Turnover | 0.00 | 0.15 | 0.17 | 0.05 | 0.10 |
| Working Capital Turnover Ratio | 0.01 | 0.87 | 0.38 | 0.08 | 0.31 |
| Cash Conversion Cycle | 2739.73 | -33.02 | -14.16 | 444.94 | -85.38 |
| Days of Sales Outstanding | 2739.73 | 68.14 | 41.91 | 342.70 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 181.27 | 0.00 |
| Days of Payables Outstanding | 0.00 | 101.16 | 56.07 | 79.03 | 85.38 |
| Operating Cycle | 2739.73 | 68.14 | 41.91 | 523.97 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.25 | -0.20 | -0.34 | -0.20 | -0.35 |
| Free Cash Flow Per Share | -0.26 | -0.23 | -0.37 | -0.22 | -0.36 |
| Dividend Paid and CapEx Coverage Ratio | -43.63 | -7.68 | -13.00 | -13.23 | -46.56 |
| Capital Expenditure Coverage Ratio | -43.63 | -7.68 | -13.00 | -13.23 | -46.56 |
| Operating Cash Flow Coverage Ratio | -17.85 | -2.27 | -25.70 | -8.29 | -8.31 |
| Operating Cash Flow to Sales Ratio | -74.97 | -3.71 | -4.39 | -6.49 | -3.20 |
| Free Cash Flow Yield | -27.12% | -33.56% | -26.91% | -13.24% | -14.10% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -3.69 | -2.34 | -6.23 | -5.03 | -11.57 |
| Price-to-Sales (P/S) Ratio | 282.76 | 12.49 | 17.60 | 52.77 | 23.16 |
| Price-to-Book (P/B) Ratio | 1.14 | 5.22 | 8.91 | 4.36 | 3.44 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -3.69 | -2.98 | -3.72 | -7.55 | -7.09 |
| Price-to-Operating Cash Flow Ratio | -3.77 | -3.37 | -4.01 | -8.13 | -7.24 |
| Price-to-Earnings Growth (PEG) Ratio | 0.36 | -0.07 | 0.19 | -0.10 | 0.00 |
| Enterprise Value Multiple | -3.37 | -2.74 | -4.39 | -5.38 | -9.74 |
| Enterprise Value | 133.95M | 73.06M | 124.73M | 163.02M | 229.36M |
| EV to EBITDA | -3.37 | -2.74 | -4.39 | -5.38 | -9.74 |
| EV to Sales | 273.37 | 11.50 | 15.79 | 52.15 | 22.95 |
| EV to Free Cash Flow | -3.56 | -2.74 | -3.33 | -7.46 | -7.03 |
| EV to Operating Cash Flow | -3.65 | -3.10 | -3.60 | -8.03 | -7.18 |
| Tangible Book Value Per Share | 0.84 | 0.13 | 0.15 | 0.38 | 0.74 |
| Shareholders’ Equity Per Share | 0.84 | 0.13 | 0.15 | 0.38 | 0.74 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.15 | 0.15 | 0.00 | -0.00 | -0.02 |
| Revenue Per Share | 0.00 | 0.05 | 0.08 | 0.03 | 0.11 |
| Net Income Per Share | -0.26 | -0.29 | -0.22 | -0.33 | -0.22 |
| Tax Burden | 0.85 | 0.85 | 1.00 | 1.00 | 1.02 |
| Interest Burden | 1.08 | 1.43 | 0.74 | 1.03 | 1.02 |
| Research & Development to Revenue | 66.52 | 5.40 | 3.75 | 10.29 | 3.29 |
| SG&A to Revenue | 5.71 | 0.00 | 0.88 | 1.03 | 0.26 |
| Stock-Based Compensation to Revenue | 0.00 | 0.09 | 0.04 | 0.86 | 0.47 |
| Income Quality | 0.98 | 0.69 | 1.55 | 0.62 | 1.64 |
Currency in EUR

